Trial Profile
Retrospective study of Daptomycin versus Vancomycin for Bloodstream Infections Caused by Methicillin-resistant Staphylococcus aureus (MRSA)
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Oct 2015
Price :
$35
*
At a glance
- Drugs Daptomycin (Primary) ; Vancomycin
- Indications Bacteraemia; Methicillin-resistant Staphylococcus aureus infections
- Focus Therapeutic Use
- 21 Oct 2015 New trial record
- 19 Sep 2015 Results presented at Joint 55th Interscience Conference on Antimicrobial Agents and Chemotherapy and 28th International Congress of Chemotherapy.